What we do

Based at the UCL School of Pharmacy in the heart of London, the Basit Research Group is a large multi-disciplinary team that brings our individual expertise together to translate drug delivery into improved patient outcomes. We have developed a number of advanced drug delivery technologies that have entered the pharmaceutical market and more importantly, to the clinic as an approved drug. To date, over a million patients worldwide have benefited from the inventions created and developed in our group. Together, and with collaboration efforts, we will continue to deliver better medicines so that patients receive a better quality of life.

Drug Delivery

With over two decades of research, our group has developed a strong understanding of the gastrointestinal system evaluating sex differences, food effects and disease states to personalise oral drug delivery.

3D Printing

Standing at the fore of developing modern pharmaceutical manufacturing techniques, our world-leading 3D printing research spans the fabrication of personalised medicines, drug delivery devices and process analytical technologies.

Digital Health

Artificial intelligence and machine learning has the potential to transform drug development. Our group aims to incorporate 3D printing, point-of-care theranostics and digital transformation into the emerging field of digital health in pharmaceutics.

publications-1

Papers & Patents

00000

Over 250 published papers and granted patents

publications-2

Citations

00000

Garnered over 15,000 citations and awarded as a 'Highly Cited Research' 2019 and 2020 Team

publications-3

Our Alumni

00000

Over 50 successful alumni working in academia, industry and biotech companies

publications-4

Products & Technologies

00000

Over 6 advanced drug delivery systems brought to market

Proudly Collaborating With

Picture7
Picture9
Picture10
Picture11
Picture12
Picture13
Picture15
Picture14
Picture16
Picture17
Picture3
Picture6
Picture2
Picture4
Picture5
astrazeneca-logo